In recent years, there has been a drastic change in the treatment landscape of several advanced cancers. Cancer immunotherapies have shown to be a viable treatment option for many patients who would have otherwise had a poor prognosis with traditional treatments, such as chemotherapy. So far the most successful subtype of cancer immunotherapies have been...
Digital services have been found to increase health-related quality of life and several aspects of patient experience. However, to achieve the positive outcomes made possible by digital services, patients need to use the services regularly and diligently. This whitepaper discusses the adoption of digital services by cancer patients. It presents several hindrances and facilitators of...
Our western healthcare systems are facing tremendous challenges. First of all, patient numbers continue to grow. Europe’s old-age dependency ratio (people +65 years old relative to those aged 15-64) is expected to increase from about 30% in 2016 to over 51% in 2070 (1). Secondly, we have better, more personalised, targeted therapies but those come...
Multiple Myeloma (MM) is a common blood cancer. Multiple Myeloma patients suffer from several disease- or treatment-related symptoms. Thus, symptom management is an important part of treating MM, and easing symptoms helps in improving patients’ quality of life. Digital symptom tracking has been shown to improve overall survival and quality of life amongst metastatic cancer...
Kaiku Health, Oulu University Hospital and Docrates Cancer Center have published first data on the symptoms reported by cancer patients receiving immune checkpoint inhibitor (ICI) therapies in a real-world setting. The purpose of the study was to investigate whether symptoms reported by cancer patients using the Kaiku Health ICI module corresponded to symptoms reported in...